| RooLife Group Ltd (RLG) ORDINARY FULLY PAID |
Communication Services |
$8 |
Maiden Made-to-Order Milk Powder Sales to JD.com
|
17 Dec 2024 8:57AM |
$0.005 |
$0.004 |
fallen by
20%
|
|
RLG - Price-sensitive ASX Announcement
Full Release
Key Points
- RLG and AULife secured first orders for own-brand milk powder from JD.com.
- Initial order valued at $200,000 for premium Australian milk powder.
- Expected strong profit contribution and increased margins for RLG.
- First shipment scheduled for delivery this month.
- Plans to scale production to meet forecast demand.
- Development of additional products under own-brand for JD.com.
- Collaboration with JD.com provides significant new sales channel.
- Aligns with RLG's strategy to expand sales in the Chinese market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| US Masters Residential Property Fund (URF) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$199 |
Update - Notification of buy-back - URF
|
17 Dec 2024 8:55AM |
$0.355 |
$0.288 |
fallen by
19.01%
|
|
| Anteris Technologies Ltd (AVR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$229 |
Reinstatement to Quotation
|
17 Dec 2024 8:53AM |
$10.540 |
$5.960 |
fallen by
43.45%
|
|
AVR - Price-sensitive ASX Announcement
Full Release
Key Points
- Anteris Technologies Global Corp. was formerly known as Anteris Technologies Limited.
- Trading suspension will be lifted following implementation of schemes of arrangement.
- The schemes involve shareholders and optionholders of Anteris Technologies Limited.
- The announcement is made under Part 5.1 of the Corporations Act 2001.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$2,418 |
Update - Notification of buy-back - NEU
|
17 Dec 2024 8:53AM |
$13.300 |
$19.095 |
risen by
43.57%
|
|
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$56 |
Neurizon Granted OMPD for NUZ-001 in Europe
|
17 Dec 2024 8:52AM |
$0.165 |
$0.105 |
fallen by
36.36%
|
|
NUZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Neurizon granted OMPD for NUZ-001 in Europe.
- NUZ-001 is aimed at treating ALS.
- The designation provides reduced regulatory fees and market exclusivity.
- Next steps include advancing preparations for the Phase 2/3 HEALEY ALS Platform Trial.
- Patient enrollment for the trial is scheduled for early H1 CY2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amotiv Limited (AOV) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,209 |
Update - Notification of buy-back - AOV
|
17 Dec 2024 8:52AM |
$10.440 |
$9.030 |
fallen by
13.51%
|
|
| Piedmont Lithium Limited (PLL) ORDINARY FULLY PAID |
Materials |
- |
Change of Director's Interest Notice
|
17 Dec 2024 8:51AM |
$0.155 |
$0.140 |
fallen by
9.68%
|
|
| Shine Justice Ltd (SHJ) ORDINARY FULLY PAID |
Consumer Discretionary |
$118 |
Update - Notification of buy-back - SHJ
|
17 Dec 2024 8:49AM |
$0.880 |
$0.695 |
fallen by
21.02%
|
|
| Ausquest Limited (AQD) ORDINARY FULLY PAID |
Materials |
$79 |
Drilling commences at Cangallo in Peru
|
17 Dec 2024 8:48AM |
$0.010 |
$0.056 |
risen by
460%
|
|
AQD - Price-sensitive ASX Announcement
Full Release
Key Points
- Maiden drill program at the Cangallo Porphyry Copper Project has commenced.
- Program will test a large-scale, undrilled porphyry copper target.
- Assay results expected around the end of January 2025.
- Reverse Circulation drilling program consists of a minimum of 8 drill-holes for a total of ~2,500m.
- The Cangallo Project is located close to significant infrastructure.
- Initial drill program will test areas with intense veining and porphyritic dykes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Torque Metals Limited (TOR) ORDINARY FULLY PAID |
Materials |
$160 |
Gold Recoveries 96.1% Paris, 96.5% HHH, 90.9% Observation
|
17 Dec 2024 8:47AM |
$0.050 |
$0.295 |
risen by
490%
|
|
TOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Gold recoveries for Paris deposit reached 96.1%.
- Gold recoveries for HHH deposit reached 96.5%.
- Gold recoveries for Observation deposit reached 90.9%.
- Gravity recoverable gold for Paris was 57.6%.
- Gravity recoverable gold for HHH was 68.8%.
- Gravity recoverable gold for Observation was 51.8%.
- Low levels of cyanide-soluble copper do not impact gold recovery.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sprintex Limited (SIX) ORDINARY FULLY PAID |
Consumer Discretionary |
$38 |
Sprintex Secures $17.5M UK Deal, Expands Global Reach
|
17 Dec 2024 8:46AM |
$0.055 |
$0.058 |
risen by
5.45%
|
|
SIX - Price-sensitive ASX Announcement
Full Release
Key Points
- Sprintex has secured A$17.5 million minimum order from Air End Repair Ltd.
- Total global commitment through distribution agreements reaches A$30 million.
- The agreement represents a five-year exclusive distribution deal in the UK.
- Sprintex's G Series Blowers are positioned for significant market growth.
- The UK Turbo Blower market is projected to grow at a CAGR of 4.3%.
- The partnership with Air End Repair supports the adoption of energy-efficient solutions.
- Quarterly minimum order targets are set to ensure consistent market penetration.
- The agreement includes options for further expansion into adjacent European markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coast Entertainment Holdings Limited (CEH) ORDINARY FULLY PAID |
Consumer Discretionary |
$194 |
Update - Notification of buy-back - CEH
|
17 Dec 2024 8:45AM |
$0.480 |
$0.500 |
risen by
4.17%
|
|
| Underwood Capital Limited (UWC) ORDINARY FULLY PAID |
Health Care |
$13 |
Update - Notification of buy-back - UWC
|
17 Dec 2024 8:42AM |
$0.049 |
$0.062 |
risen by
26.53%
|
|
| PlaySide Studios Limited (PLY) ORDINARY FULLY PAID |
Communication Services |
$99 |
Proposed issue of securities - PLY
|
17 Dec 2024 8:42AM |
$0.405 |
$0.220 |
fallen by
45.68%
|
|
| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$53 |
Cleansing Notice
|
17 Dec 2024 8:38AM |
$0.860 |
$0.470 |
fallen by
45.35%
|
|
| NOVONIX Limited (NVX) ORDINARY FULLY PAID |
Information Technology |
$378 |
Conditional Commitment for US$754M Loan from US DOE LPO
|
17 Dec 2024 8:38AM |
$0.585 |
$0.450 |
fallen by
23.08%
|
|
NVX - Price-sensitive ASX Announcement
Full Release
Key Points
- NOVONIX received a conditional commitment for a US$754.8 million loan from the U.S. DOE.
- The loan aims to finance a new synthetic graphite manufacturing plant in Chattanooga, Tennessee.
- The facility will produce approximately 31,500 tonnes of synthetic graphite per annum.
- The production will support the manufacture of batteries for around 325,000 electric vehicles each year.
- The facility is expected to create 450 full-time jobs and 500 construction jobs.
- This project underscores the focus on localizing critical battery materials in the U.S.
- NOVONIX has signed offtake agreements with major partners like Panasonic and Stellantis.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MAAS Group Holdings Limited (MGH) ORDINARY FULLY PAID |
Industrials |
$1,664 |
Notification regarding unquoted securities - MGH
|
17 Dec 2024 8:38AM |
$4.710 |
$4.575 |
fallen by
2.87%
|
|
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$29 |
Change of Company Auditor
|
17 Dec 2024 8:38AM |
$0.083 |
$0.090 |
risen by
8.43%
|
|
| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$53 |
Application for quotation of securities - LTP
|
17 Dec 2024 8:37AM |
$0.860 |
$0.470 |
fallen by
45.35%
|
|
| National Australia Bank Limited (NAB) ORDINARY FULLY PAID |
Financials |
$122,170 |
Notification of cessation of securities - NAB
|
17 Dec 2024 8:37AM |
$37.640 |
$39.880 |
risen by
5.95%
|
|
| Southern Cross Gold Ltd (SXG) ORDINARY FULLY PAID |
Materials |
- |
SXG Receives FIRB Approval to Acquire Land
|
17 Dec 2024 8:34AM |
$4.040 |
$3.450 |
fallen by
14.60%
|
|
SXG - Price-sensitive ASX Announcement
Full Release
Key Points
- SXG received FIRB approval for land acquisition.
- Acquisition involves a share swap for Sparr Nominees Pty Ltd.
- Sparr owns 921.22 hectares of agricultural land.
- SXG's total landholding at Sunday Creek will increase to 1,054.51 hectares.
- The deal secures significant cash and land for SXG's future projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aristocrat Leisure Limited (ALL) ORDINARY FULLY PAID |
Consumer Discretionary |
$36,229 |
Update - Notification of buy-back - ALL
|
17 Dec 2024 8:33AM |
$67.940 |
$58.730 |
fallen by
13.56%
|
|
| Southern Cross Media Group Limited (SXL) ORDINARY FULLY PAID |
Communication Services |
$192 |
SCA to sell 3-Agg television licences to Network 10
|
17 Dec 2024 8:31AM |
$0.560 |
$0.800 |
risen by
42.86%
|
|
SXL - Price-sensitive ASX Announcement
Full Release
Key Points
- SCA is selling television licenses in three aggregated markets to Network 10.
- The sale is part of a strategic review of non-core regional assets.
- Completion of the sale is expected by February 2025.
- SCA will earn a share of profits from the licenses for five years after the sale.
- Expected earnings from the sale range from $15 million to $20 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| National Australia Bank Limited (NAB) ORDINARY FULLY PAID |
Financials |
$122,170 |
Update - Notification of buy-back - NAB
|
17 Dec 2024 8:31AM |
$37.640 |
$39.880 |
risen by
5.95%
|
|
| Genetic Signatures Limited (GSS) ORDINARY FULLY PAID |
Health Care |
$65 |
Change of Director's Interest Notice
|
17 Dec 2024 8:31AM |
$0.640 |
$0.285 |
fallen by
55.47%
|
|